Folia Parasitologica 69:020 (2022) | DOI: 10.14411/fp.2022.020

Polarisation of human macrophages towards an M1 subtype triggered by an atypical Brazilian strain of Toxoplasma gondii results in a reduction in parasite burden

Paula Suellen Guimarães Gois1, Priscila Silva Franco1, Samuel Cota Teixeira1, Pâmela Mendonça Guirelli1, Thádia Evelyn de Araújo1, Deivid William da Fonseca Batistão1, Fernanda Chaves de Oliveira1, Gabriela Lícia Santos Ferreira2, Angelica de Oliveira Gomes3, Silvio Favoreto Jr.4, José Roberto Mineo5, Bellisa de Freitas Barbosa1, Eloisa Amália Vieira Ferro ORCID...1
1 Universidade Federal de Uberlândia, Laboratory of Immunophysiology of Reproduction, Campus Umuarama, Uberlândia, Minas Gerais, Brazil;
2 Universidade Federal de Uberlândia, Faculdade de Ciências Integradas do Pontal, Laboratory of Biological Experimentation, Ituiutaba, Minas Gerais, Brazil;
3 Universidade Federal do Triângulo Mineiro, Department of Structural Biology, Uberaba, Minas Gerais, Brazil;
4 Cuesta College, Department of Biological Sciences, San Luis Obispo, California, USA;
5 Universidade Federal de Uberlândia, Laboratory of Immunoparasitology, Campus Umuarama, Uberlândia, Minas Gerais, Brazil

Toxoplasma gondii Nicolle et Manceaux, 1909, the etiologic agent of toxoplasmosis, was considered a clonal population with three distinct genetic lineages (I, II and III); however, sequence analysis of different strains has revealed distinct atypical genotypes. Macrophages are essential for immunity against toxoplasmosis and differential cell regulation may affect the course of the disease. In this context, our study aims to investigate the infection by TgChBrUD2, a highly virulent atypical Brazilian strain of T. gondii, on the activation and polarisation of human macrophages. Human macrophage-like cells obtained from THP-1 cells were infected with TgChBrUD2, RH or ME49 strains of T. gondii to evaluate the impact of parasite infection on macrophage polarisation. Our results indicate that the TgChBrUD2 and ME49 strains of T. gondii induced a classic activation of human macrophages, which was confirmed by the high rate of spindle-shaped macrophages, low amount of urea and increase in the levels of nitrite, as well as the down-regulation of M2-markers. In contrast, RH strain promoted an alternative activation of macrophages. The polarisation of human macrophages towards an M1 subtype mediated by TgChBrUD2 and ME49 strains resulted in a low parasite burden, with high levels of IL-6 and MIF. Finally, the M2 subtype triggered by the RH strain culminated in a lower intracellular proliferation index. We concluded that the atypical (TgChBrUD2) and clonal (ME49) strains are able to elicit an M1 subtype, which results in parasitism control, partially explained by the high levels of IL-6 and MIF produced during the infection by these genotypes. In contrast, the clonal (RH) strain promoted a macrophage polarisation towards an M2 subtype, marked by a high parasite burden, with a weak modulation of pro-inflammatory cytokines. Thus, atypical strains can present different mechanisms of pathogenicity and transmissibility compared to clonal strains, as well as they can use distinct strategies to evade the host's immune response and ensure their survival.

Keywords: clonal strains, macrophage polarisation, toxoplasmosis, TgChBrUD2 strain

Received: December 8, 2021; Revised: May 8, 2022; Accepted: June 16, 2022; Published online: October 4, 2022  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Guimarães Gois, P.S., Franco, P.S., Cota Teixeira, S., Guirelli, P.M., de Araújo, T.E., da Fonseca Batistão, D.W., ... Ferro, E.A.V. (2022). Polarisation of human macrophages towards an M1 subtype triggered by an atypical Brazilian strain of Toxoplasma gondii results in a reduction in parasite burden. Folia Parasitologica69, Article 2022.020. https://doi.org/10.14411/fp.2022.020
Download citation

References

  1. Aguirre A.A., Longcore T., Barbieri M., Dabritz H., Hill D., Klein P.N., Lepczyk C., Lilly E.L., McLeod R., Milcarsky J., Murphy C.E., Su C., VanWormer E., Yolken R., Sizemore G.C. 2019: The one health approach to toxoplasmosis: epidemiology, control, and prevention strategies. Ecohealth 16: 378-390. Go to original source... Go to PubMed...
  2. Akinrinmade O.A., Chetty S., Daramola A.K., Islam M.-u., Thepen T., Barth S. 2017: CD64: An attractive immunotherapeutic target for M1-type macrophage mediated chronic inflammatory diseases. Biomedicines 5: 56. Go to original source... Go to PubMed...
  3. Aldridge J.R., Moseley C.E., Boltz D.A., Negovetich N.J., Reynolds C., Franks J., Brown S.A., Doherty P.C., Webster R.G., Thomas P.G. 2009: TNF/iNOS-producing dendritic cells are the necessary evil of lethal influenza virus infection. Proc. Natl. Acad. Sci. USA 106: 5306-5311. Go to original source... Go to PubMed...
  4. Angeloni M.B., Guirelli P.M., Franco P.S., Barbosa B.F., Gomes A.O., Castro A.S., Silva N.M., Martins-Filho O.A., Mineo T.W., Silva D.A., Mineo J.R., Ferro E.A. 2013: Differential apoptosis in BeWo cells after infection with highly (RH) or moderately (ME49) virulent strains of Toxoplasma gondii is related to the cytokine profile secreted, the death receptor fas expression and phosphorylated ERK1/2 expression. Placenta 34: 973-982. Go to original source... Go to PubMed...
  5. Angeloni M.B., Silva N.M., Castro A.S., Gomes A.O., Silva D.A.O., Mineo J.R., Ferro E.A.V. 2009: Apoptosis and S phase of the cell cycle in BeWo trophoblastic and HeLa cells are differentially modulated by Toxoplasma gondii strain types. Placenta 30: 785-791. Go to original source... Go to PubMed...
  6. Barbosa B.F., Lopes-Maria J.B., Gomes A.O., Angeloni M.B., Castro A.S., Franco P.S., Fermino M.L., Roque-Barreira M.C., Ietta F., Martins-Filho O.A., Silva D.A., Mineo J.R., Ferro E.A. 2015: IL10, TGF beta1, and IFN gamma modulate intracellular signaling pathways and cytokine production to control Toxoplasma gondii infection in BeWo trophoblast cells. Biol. Reprod. 92: 82. Go to original source... Go to PubMed...
  7. Bigna J.J., Tochie J.N. 2019: Global, regional and national estimates of Toxoplasma gondii seroprevalence in pregnant women: a protocol for a systematic review and modelling analysis. B.M.J. Open 9: e030472. Go to original source... Go to PubMed...
  8. Campos M.A.S., Gilbert R.E., Freeman K., Lago E.G., Bahia-Oliveira L.M.G., Tan H.K., Wallon M., Buffolano W., Stanford M.R., Petersen E. 2008: Ocular sequelae of congenital toxoplasmosis in Brazil compared with Europe. PLoS Negl. Trop. Dis. 2: e277. Go to original source... Go to PubMed...
  9. Carneiro A.C.A.V., Andrade G.M., Costa J.G.L., Pinheiro B.V., Vasconcelos-Santos D.V., Ferreira A.M., Su C., Januário J.N., Vitor R.W.A. 2013: Genetic characterizationof Toxoplasma gondii revealed highly diverse genotypes for isolates from newborns with congenital toxoplasmosis in Southeastern Brazil. J. Clin. Microbiol. 51: 901-907. Go to original source... Go to PubMed...
  10. Castro A.S., Alves C.M., Angeloni M.B., Gomes A.O., Barbosa B.F., Franco P.S., Silva D.A., Martins-Filho O.A., Mineo J.R., Mineo T.W., Ferro E.A. 2013: Trophoblast cells are able to regulate monocyte activity to control Toxoplasma gondii infection. Placenta 34: 240-247. Go to original source... Go to PubMed...
  11. Comalada M., Yeramian A., Modolell M., Lloberas J., Celada A. 2012: Arginine and macrophage activation. Methods Mol. Biol. 844: 223-235. Go to original source... Go to PubMed...
  12. Dardé M.L. 2008: Toxoplasma gondii, "new" genotypes and virulence. Parasite 15: 366-371. Go to original source... Go to PubMed...
  13. de Barros R.A.M., Torrecilhas A.C., Marciano M.A.M., Mazuz M.L., Pereira-Chioccola V.L., Fux B. 2022: Toxoplasmosis in human and animals around the world. Diagnosis and perspectives in the one health approach. Acta Trop. 231: 106432. Go to original source... Go to PubMed...
  14. de Oliveira Gomes A., de Oliveira Silva D.A., Silva N.M., de Freitas Barbosa B., Franco P.S., Angeloni M.B., Fermino M.L., Roque-Barreira M.C., Bechi N., Paulesu L.R., Dos Santos M.C., Mineo J.R., Ferro E.A. 2011: Effect of macrophage migration inhibitory factor (MIF) in human placental explants infected with Toxoplasma gondii depends on gestational age. Am. J. Pathol. 178: 2792-2801. Go to original source... Go to PubMed...
  15. Dubey J., Jones J. 2008: Toxoplasma gondii infection in humans and animals in the United States. Int. J. Parasitol. 38: 1257-1278. Go to original source... Go to PubMed...
  16. Dubey J.P., Lago E.G., Gennari S.M., Su C., Jones J.L. 2012: Toxoplasmosis in humans and animals in Brazil: high prevalence, high burden of disease, and epidemiology. Parasitology 139: 1375-1424. Go to original source... Go to PubMed...
  17. Dubey J.P., Velmurugan G.V., Rajendran C., Yabsley M.J., Thomas N.J., Beckmen K.B., Sinnett D., Ruid D., Hart J., Fair P.A., McFee W.E., Shearn-Bochsler V., Kwok O.C.H., Ferreira L.R., Choudhary S., Faria E.B., Zhou H., Felix T.A., Su C. 2011: Genetic characterisation of Toxoplasma gondii in wildlife from North America revealed widespread and high prevalence of the fourth clonal type. Int. J. Parasitol. 41: 1139-1147. Go to original source... Go to PubMed...
  18. Dunay I.R., DaMatta R.A., Fux B., Presti R., Greco S., Colonna M., Sibley L.D. 2008: Gr1+ Inflammatory Monocytes Are Required for Mucosal Resistance to the Pathogen Toxoplasma gondii. Immunity 29: 306-317. Go to original source... Go to PubMed...
  19. Ferreira I.M.R., Vidal J.E., de Mattos C.d.C.B., de Mattos L.C., Qu D., Su C., Pereira-Chioccola V.L. 2011: Toxoplasma gondii isolates: Multilocus RFLP-PCR genotyping from human patients in Sao Paulo State, Brazil identified distinct genotypes. Exp. Parasitol. 129: 190-195. Go to original source... Go to PubMed...
  20. Ferro E.A., Mineo J.R., Ietta F., Bechi N., Romagnoli R., Silva D.A., Sorda G., Bevilacqua E., Paulesu L.R. 2008: Macrophage migration inhibitory factor is up-regulated in human first-trimester placenta stimulated by soluble antigen of Toxoplasma gondii, resulting in increased monocyte adhesion on villous explants. Am. J. Pathol. 172: 50-58. Go to original source... Go to PubMed...
  21. Flores M., Saavedra R., Bautista R., Viedma R., Tenorio E.P., Leng L., Sanchez Y., Juárez I., Satoskar A.A., Shenoy A.S., Terrazas L.I., Bucala R., Barbi J., Satoskar A.R., Rodriguez-Sosa M. 2008: Macrophage migration inhibitory factor (MIF) is critical for the host resistance against Toxoplasma gondii. FASEB J. 22: 3661-3671. Go to original source... Go to PubMed...
  22. Fox B.A., Guevara R.B., Rommereim L.M., Falla A., Bellini V., Pètre G., Rak C., Cantillana V., Dubremetz J.-F., Cesbron-Delauw M.-F., Taylor G.A., Mercier C., Bzik D.J., Weiss L.M. 2019: Toxoplasma gondii parasitophorous vacuole membrane-associated dense granule proteins orchestrate chronic infection and GRA12 underpins resistance to host gamma interferon. mBio. 10: e00589-19. Go to original source... Go to PubMed...
  23. Franco P.S., da Silva N.M., de Freitas Barbosa B., de Oliveira Gomes A., Ietta F., Shwab E.K., Su C., Mineo J.R., Ferro E.A.V. 2015: Calomys callosus chronically infected by Toxoplasma gondii clonal type II strain and reinfected by Brazilian strains is not able to prevent vertical transmission. Front. Microbiol. 6: 181. Go to original source... Go to PubMed...
  24. Franco P.S., Gois P.S.G., de Araujo T.E., da Silva R.J., de Freitas Barbosa B., de Oliveira Gomes A., Ietta F., Dos Santos L.A., Dos Santos M.C., Mineo J.R., Ferro E.A.V. 2019: Brazilian strains of Toxoplasma gondii are controlled by azithromycin and modulate cytokine production in human placental explants. J. Biomed. Sci. 26: 10. Go to original source... Go to PubMed...
  25. Franco P.S., Ribeiro M., Lopes-Maria J.B., Costa L.F., Silva D.A.O., de Freitas Barbosa B., de Oliveira Gomes A., Mineo J.R., Ferro E.A.V. 2014: Experimental infection of Calomys callosus with atypical strains of Toxoplasma gondii shows gender differences in severity of infection. Parasitol. Res. 113: 2655-2664. Go to original source... Go to PubMed...
  26. Gómez-Chávez F., Cañedo-Solares I., Ortiz-Alegría L.B., Flores-García Y., Figueroa-Damián R., Luna-Pastén H., Gómez-Toscano V., López-Candiani C., Arce-Estrada G.E., Bonilla-Ríos C.A., Mora-González J.C., García-Ruiz R., Correa D. 2020: A Proinflammatory immune response might determine Toxoplasma gondii vertical transmission and severity of clinical features in congenitally infected newborns. Front. Immunol. 11: 390. Go to original source... Go to PubMed...
  27. Green L.C., Wagner D.A., Glogowski J., Skipper P.L., Wishnok J.S., Tannenbaum S.R. 1982: Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids. Anal. Biochem. 126: 131-138. Go to original source... Go to PubMed...
  28. Grigg M.E., Ganatra J., Boothroyd John C., Margolis Todd P. 2001: Unusual abundance of atypical strains associated with human ocular toxoplasmosis. J. Infect. Dis. 184: 633-639. Go to original source... Go to PubMed...
  29. Hakimi M.A., Mammari N., Vignoles P., Halabi M.A., Darde M.L., Courtioux B. 2014: In vitro infection of human nervous cells by two strains of Toxoplasma gondii: a kinetic analysis of immune mediators and parasite multiplication. PLoS ONE 9: e98491. Go to original source... Go to PubMed...
  30. Halonen S.K., Weiss L.M. 2013: Toxoplasmosis. 114: 125-145.
  31. Hampton M.M. 2015: Congenital toxoplasmosis: a review. Neonatal Netw. 34: 274-278. Go to original source... Go to PubMed...
  32. Händel U., Brunn A., Drögemüller K., Müller W., Deckert M., Schlüter D. 2012: Neuronal gp130 expression is crucial to prevent neuronal loss, hyperinflammation, and lethal course of murine Toxoplasma encephalitis. Am. J. Pathol. 181: 163-173. Go to original source... Go to PubMed...
  33. Howe D.K., Sibley L.D. 1995: Toxoplasma gondii comprises three clonal lineages: correlation of parasite genotype with human disease. J. Infect .Dis. 172: 1561-1566. Go to original source... Go to PubMed...
  34. Hunter C.A., Sibley L.D. 2012: Modulation of innate immunity by Toxoplasma gondii virulence effectors. Nat. Rev. Microbiol. 10: 766-778. Go to original source... Go to PubMed...
  35. Ishikawa T., Harada T., Koi H., Kubota T., Azuma H., Aso T. 2007: Identification of arginase in human placental villi. Placenta 28: 133-138. Go to original source... Go to PubMed...
  36. Italiani P., Boraschi D. 2014: From monocytes to M1/M2 macrophages: phenotypical vs. functional differentiation. Front. Immunol. 5: 514. Go to original source... Go to PubMed...
  37. Jaguin M., Houlbert N., Fardel O., Lecureur V. 2013: Polarization profiles of human M-CSF-generated macrophages and comparison of M1-markers in classically activated macrophages from GM-CSF and M-CSF origin. Cell. Immunol. 281: 51-61. Go to original source... Go to PubMed...
  38. Jensen K.D.C., Camejo A., Melo M.B., Cordeiro C., Julien L., Grotenbreg G.M., Frickel E.-M., Ploegh H.L., Young L., Saeij J.P.J., Weiss L.M. 2015: Toxoplasma gondii superinfection and virulence during secondary infection correlate with the exact ROP5/ROP18 allelic combination. mBio 6: e02280-14. Go to original source... Go to PubMed...
  39. Jensen Kirk D.C., Wang Y., Wojno Elia D.T., Shastri Anjali J., Hu K., Cornel L., Boedec E., Ong Y.-C., Chien Y.-h., Hunter Christopher A., Boothroyd John C., Saeij Jeroen P.J. 2011: Toxoplasma polymorphic effectors determine macrophage polarization and intestinal inflammation. Cell Host Microbe. 9: 472-483. Go to original source... Go to PubMed...
  40. Khan A. 2006: Genetic divergence of Toxoplasma gondii strains associated with ocular toxoplasmosis, Brazil. Emerg. Infect. Dis. 12: 942-949. Go to original source... Go to PubMed...
  41. Khan A., Dubey J.P., Su C., Ajioka J.W., Rosenthal B.M., Sibley L.D. 2011: Genetic analyses of atypical Toxoplasma gondii strains reveal a fourth clonal lineage in North America. Int. J. Parasitol. 41: 645-655. Go to original source... Go to PubMed...
  42. Kong L., Zhang Q., Chao J., Wen H., Zhang Y., Chen H., Pappoe F., Zhang A., Xu X., Cai Y., Li M., Luo Q., Zhang L., Shen J. 2015: Polarization of macrophages induced by Toxoplasma gondii and its impact on abnormal pregnancy in rats. Acta Trop. 143: 1-7. Go to original source... Go to PubMed...
  43. Li Z., Zhao M., Li T., Zheng J., Liu X., Jiang Y., Zhang H., Hu X. 2017: Decidual macrophage functional polarization during abnormal pregnancy due to Toxoplasma gondii: role for LILRB4. Front. Immunol. 8: 1013. Go to original source... Go to PubMed...
  44. Liu T., Zhang Q., Liu L., Xu X., Chen H., Wang H., Kong L., Wang W., Zhang A., Cai Y., Li M., Yu L., Du J., Wang X., Luo Q., Lun Z.-R., Wang Y., Shen J. 2013: Trophoblast apoptosis through polarization of macrophages induced by Chinese Toxoplasma gondii isolates with different virulence in pregnant mice. Parasitol. Res. 112: 3019-3027. Go to original source... Go to PubMed...
  45. Lopes C.S., Franco P.S., Silva N.M., Silva D.A.O., Ferro E.A.V., Pena H.F.J., Soares R.M., Gennari S.M., Mineo J.R. 2016: Phenotypic and genotypic characterization of two Toxoplasma gondii isolates in free-range chickens from Uberlândia, Brazil. Epidemiol. Infect. 144: 1865-1875. Go to original source... Go to PubMed...
  46. Lüder C.G.K., Stanway R.R., Chaussepied M., Langsley G., Heussler V.T. 2009: Intracellular survival of apicomplexan parasites and host cell modification. Int. J. Parasitol. 39: 163-173. Go to original source... Go to PubMed...
  47. Mantovani A., Sica A., Sozzani S., Allavena P., Vecchi A., Locati M. 2004: The chemokine system in diverse forms of macrophage activation and polarization. Trends. Immunol. 25: 677-686. Go to original source... Go to PubMed...
  48. Melo M.B., Jensen K.D.C., Saeij J.P.J. 2011: Toxoplasma gondii effectors are master regulators of the inflammatory response. Trends Parasitol. 27: 487-495. Go to original source... Go to PubMed...
  49. Mills C. 2012: M1 and M2 macrophages: oracles of health and disease. Crit. Rev. Immunol. 32: 463-488. Go to original source... Go to PubMed...
  50. Montoya J.G., Liesenfeld O. 2004: Toxoplasmosis. Lancet 363: 1965-1976. Go to original source... Go to PubMed...
  51. Mordue D.G., Monroy F., La Regina M., Dinarello C.A., Sibley L.D. 2001: Acute toxoplasmosis leads to lethal overproduction of Th1 cytokines. J. Immunol. 167: 4574-4584. Go to original source... Go to PubMed...
  52. Mukhopadhyay D., Sangaré L.O., Braun L., Hakimi M.A., Saeij J.P.J. 2020: Toxoplasma GRA15 limits parasite growth in IFNγ-activated fibroblasts through TRAF ubiquitin ligases. EMBO J. 39. Go to original source...
  53. Murray P. J. 2011: Macrophages as a battleground for Toxoplasma pathogenesis. Cell Host Microbe. 9: 445-447. Go to original source... Go to PubMed...
  54. Murray P.J., Wynn T.A. 2011: Obstacles and opportunities for understanding macrophage polarization. J. Leukoc. Biol. 89: 557-563. Go to original source... Go to PubMed...
  55. Nguyen T.D., Bigaignon G., Markine-Goriaynoff D., Heremans H., Nguyen T.N., Warnier G., Delmee M., Warny M., Wolf S.F., Uyttenhove C., Van Snick J., Coutelier J.P. 2003: Virulent Toxoplasma gondii strain RH promotes T-cell-independent overproduction of proinflammatory cytokines IL12 and γ-interferon. J. Med. Microbiol. 52: 869-876. Go to original source... Go to PubMed...
  56. Ning F., Liu H., Lash G.E. 2016: The role of cecidual macrophages during normal and pathological pregnancy. Am. J. Reprod. Immunol. 75: 298-309. Go to original source... Go to PubMed...
  57. Orecchioni M., Ghosheh Y., Pramod A.B., Ley K. 2019: Macrophage Polarization: Different gene signatures in M1(LPS+) vs. classically and M2(LPS-) vs. alternatively activated macrophages. Front. Immunol. 10: 1084. Go to original source... Go to PubMed...
  58. Park E.K., Jung H.S., Yang H.I., Yoo M.C., Kim C., Kim K.S. 2007: Optimized THP-1 differentiation is required for the detection of responses to weak stimuli. Inflamm. Res. 56: 45-50. Go to original source... Go to PubMed...
  59. Park J., Hunter C.A. 2020: The role of macrophages in protective and pathological responses to Toxoplasma gondii. Parasite Immunol. 42: e12712. Go to original source... Go to PubMed...
  60. Pena H.F.J., Gennari S.M., Dubey J.P., Su C. 2008: Population structure and mouse-virulence of Toxoplasma gondii in Brazil. Int. J. Parasitol. 38: 561-569. Go to original source... Go to PubMed...
  61. Porcheray F., Viaud S., Rimaniol A.C., Leone C., Samah B., Dereuddre-Bosquet N., Dormont D., Gras G. 2005: Macrophage activation switching: an asset for the resolution of inflammation. Clin. Exp. Immunol. 142: 481-489. Go to original source... Go to PubMed...
  62. Radke J. 2001: Defining the cell cycle for the tachyzoite stage of Toxoplasma gondii. Mol. Biochem. Parasitol. 115: 165-175. Go to original source... Go to PubMed...
  63. Rajendran C., Su C., Dubey J.P. 2012: Molecular genotyping of Toxoplasma gondii from Central and South America revealed high diversity within and between populations. Infect. Genet. Evol. 12: 359-368. Go to original source... Go to PubMed...
  64. Reese M.L., Shah N., Boothroyd J.C. 2014: The Toxoplasma pseudokinase ROP5 is an allosteric inhibitor of the immunity-related GTPases. J. Biol. Chem. 289: 27849-27858. Go to original source... Go to PubMed...
  65. Reyes L., Moore R.N., Davidson M.K., Thomas L.C., Davis J.K. 1999: Effects of Mycoplasma fermentans incognitus on differentiation of THP-1 cells. Infect. Immun. 67: 3188-3192. Go to original source... Go to PubMed...
  66. Ribeiro M., Franco P.S., Lopes-Maria J.B., Angeloni M.B., Barbosa B.d.F., Gomes A.d.O., Castro A.S., Silva R.J.d., Oliveira F.C.d., Milian I.C.B., Martins-Filho O.A., Ietta F., Mineo J.R., Ferro E.A.V. 2017: Azithromycin treatment is able to control the infection by two genotypes of Toxoplasma gondii in human trophoblast BeWo cells. Exp. Parasitol. 181: 111-118. Go to original source... Go to PubMed...
  67. Rico-Torres C.P., Vargas-Villavicencio J.A., Correa D. 2016: Is Toxoplasma gondii type related to clinical outcome in human congenital infection? Systematic and critical review. Eur. J. Clin. Microbiol. Infect. Dis. 35: 1079-1088. Go to original source... Go to PubMed...
  68. Saadatnia G., Golkar M. 2012: A review on human toxoplasmosis. Scand. J. Infect. Dis. 44: 805-814. Go to original source... Go to PubMed...
  69. Saeij J.P.J., Boyle J.P., Boothroyd J.C. 2005: Differences among the three major strains of Toxoplasma gondii and their specific interactions with the infected host. Trends Parasitol. 21: 476-481. Go to original source... Go to PubMed...
  70. Sauer A., de la Torre A., Gomez-Marin J., Bourcier T., Garweg J., Speeg-Schatz C., Candolfi E. 2011: Prevention of retinochoroiditis in congenital toxoplasmosis: Europe versus South America. Pediatr. Infect. Dis. J. 30: 601-603. Go to original source... Go to PubMed...
  71. Shwab E.K., Zhu X.-Q., Majumdar D., Pena H.F.J., Gennari S.M., Dubey J.P., Su C. 2013: Geographical patterns of Toxoplasma gondii genetic diversity revealed by multilocus PCR-RFLP genotyping. Parasitology 141: 453-461. Go to original source... Go to PubMed...
  72. Sibley L.D., Ajioka J.W. 2008: Population structure of Toxoplasma gondii: clonal expansion driven by infrequent recombination and selective sweeps. Annu. Rev. Microbiol. 62: 329-351. Go to original source... Go to PubMed...
  73. Sibley L.D., Blackwell J., Newbold C., Turner M., Vickerman K., Mordue D.G., Su C., Robben P.M., Howe D.K. 2002: Genetic approaches to studying virulence and pathogenesis in Toxoplasma gondii. Philos. Trans. R. Soc. Lond. B Biol. Sci. 357: 81-88. Go to original source... Go to PubMed...
  74. Stopić M., ©tajner T., Marković-Denić L., Nikolić V., Djilas I., Srzentić S.J., Djurković-Djaković O., Bobić B. 2022: Epidemiology of toxoplasmosis in Serbia: a cross-sectional study on blood donors. Microorganisms 10: 492. Go to original source... Go to PubMed...
  75. Su C., Khan A., Zhou P., Majumdar D., Ajzenberg D., Darde M.L., Zhu X.Q., Ajioka J.W., Rosenthal B.M., Dubey J.P., Sibley L.D. 2012: Globally diverse Toxoplasma gondii isolates comprise six major clades originating from a small number of distinct ancestral lineages. Proc. Natl. Acad. Sci. USA 109: 5844-5849. Go to original source... Go to PubMed...
  76. Teixeira S.C., de Souza G., Borges B.C., de Araújo T.E., Rosini A.M., Aguila F.A., Ambrósio S.R., Veneziani R.C.S., Bastos J.K., Silva M.J.B., Martins C.H.G., de Freitas Barbosa B., Ferro E.A.V. 2020: Copaifera spp. oleoresins impair Toxoplasma gondii infection in both human trophoblastic cells and human placental explants. Sci. Rep. 10: 15158. Go to original source... Go to PubMed...
  77. Vallochi A.L., Muccioli C., Martins M.C., Silveira C., Belfort R., Rizzo L.V. 2005: The genotype of Toxoplasma gondii strains causing ocular toxoplasmosis in humans in Brazil. Am. J. Ophthalmol. 139: 350-351. Go to original source... Go to PubMed...
  78. Verreck F.A.W., de Boer T., Langenberg D.M.L., Hoeve M.A., Kramer M., Vaisberg E., Kastelein R., Kolk A., de Waal-Malefyt R., Ottenhoff T.H.M. 2004: Human IL-23-producing type 1 macrophages promote but IL-10-producing type 2 macrophages subvert immunity to (myco)bacteria. Proc. Natl. Acad. Sci. USA 101: 4560-4565. Go to original source... Go to PubMed...
  79. Vogel D.Y.S., Glim J.E., Stavenuiter A.W.D., Breur M., Heijnen P., Amor S., Dijkstra C.D., Beelen R.H.J. 2014: Human macrophage polarization in vitro: maturation and activation methods compared. Immunobiology 219: 695-703. Go to original source... Go to PubMed...
  80. Wahab T., Edvinsson B., Palm D., Lindh J. 2009: Comparison of the AF146527 and B1 repeated elements, two real-time PCR targets used for detection of Toxoplasma gondii. J. Clin. Microbiol. 48: 591-592. Go to original source... Go to PubMed...
  81. Waldo S.W., Li Y., Buono C., Zhao B., Billings E.M., Chang J., Kruth H.S. 2008: Heterogeneity of human macrophages in culture and in atherosclerotic plaques. Am. J. Pathol. 172: 1112-1126. Go to original source... Go to PubMed...
  82. Wang W.-J., Hao C.-F., Lin Q.-D. 2011: Dysregulation of macrophage activation by decidual regulatory T cells in unexplained recurrent miscarriage patients. J. Reprod. Immunol. 92: 97-102. Go to original source... Go to PubMed...
  83. Wang Y., Sangaré L.O., Paredes-Santos T.C., Hassan M.A., Krishnamurthy S., Furuta A.M., Markus B.M., Lourido S., Saeij J.P.J. 2020: Genome-wide screens identify Toxoplasma gondii determinants of parasite fitness in IFNγ-activated murine macrophages. Nat. Commun. 11: 5258. Go to original source... Go to PubMed...
  84. Yao Y., Xu X.-H., Jin L. 2019: Macrophage polarization in physiological and pathological pregnancy. Front. Immunol. 10: 792. Go to original source... Go to PubMed...
  85. Yarovinsky F. 2008: Toll-like receptors and their role in host resistance to Toxoplasma gondii. Immunol. Lett. 119: 17-21. Go to original source... Go to PubMed...